It details how the factors that drove clinical use–patient demand, physician enthusiasm, media reporting, litigation, economic exploitation, and legislative and administrative mandates–converged to propel the procedure forward despite a lack of proven clinical effectiveness. It also analyzes the limited effect of technology assessments before randomized clinical trials evaluated decisively the procedure and the ramifications of this system on healthcare today.
Sections of the book consider the initial conditions surrounding the emergence of the new breast cancer treatment, the drivers of clinical use, and the struggle for evidence-based medicine. A concluding section considers the significance of the story for our healthcare system.
eBook features:
- Highlight, take notes, and search in the book
- In this edition, page numbers are just like the physical edition
_hbpbqeiots.jpg)
_idmgqlrt91.jpg)
_czggxxd6hy.jpg)
_ay0l9q7pd9.jpg)
